Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2558-2561

  Tankovic, Jacques ^a,b   Mahjoubi, Faouzia ^a   Courvalin, Patrice ^b   Duval, Jean ^a   Leclercq, Roland ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

EID: 0029956751     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2558     Document Type: Article

References (24)

1. Acar, J., H. Chardon, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, J. P. Flandrois, F. Goldstein, C. Morel, A. Philippon, B. Rouveix, J. Sirot, and A. Thabaut. 1995. Communiqué 1995 du Comité de l'Antibiogramme de la Société Française de Microbiologie. Pathol. Biol. 43:I-VIII.
2. Baddour, L. M., D. V. Hicks, M. M. Tayidi, S. K. Roberts, E. Walker, R. J. Smith, D. S. Sweitzer, J. A. Herrington, and B. G. Painter. 1995. Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospital. Microb. Drug Resist. 1:219-222.
3. Eliopoulos, G. M. 1993. Increasing problems in the therapy of enterococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 12:409-412.
4. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-seleclcd ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
5. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wolfe, and B. Walters. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin. Infect. Dis. 16:750-753.
6. Jacob, A. E., and S. J. Hobbs. 1974. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J. Bacteriol. 117:360-372.
7. Jones, R. N., and A. L. Barry. 1990. In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone. Antimicrob. Agents Chemother. 34:306-313.
8. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1086-1094.
9. Korten, V., W. M. Huang, and B. E. Murray. 1994. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterticoccus faecalis. Antimicrob. Agents Chemother. 38:2091-2094.
10. Midgley, M. 1994. Characteristics of an ethidium efflux system in Enterococcus hirae. FEMS Microbiol. Lett. 120:119-124.
11. Murray, B. E. 1990. The life and times of the enterococcus. Clin. Microbiol. Rev. 3:46-65.
12. Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.
13. Nakanishi, N., S. Yoshida, H. Wakebe, M. Inoue, and S. Mitsuhashi. 1991. Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis. Antimicrob. Agents Chemother. 35:1053-1059.
14. Sahm, D. F., and G. T. Koburov. 1989. In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrob. Agents Chemother. 33:71-77.
15. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
16. Sato, K., K. Hoshino, M. Tanaka, I. Hayakawa, and Y. Osada. 1992. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob. Agents Chemother. 36:1491-1498.
17. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infections. Am. J. Med. 91(Suppl. 3B):72-75.
18. Schaberg, D. R., W. I. Dillon, M. S. Terpenning, K. A. Robinson, S. F. Bradley, and C. A. Kauffman. 1992. Increasing resistance of enterococci to ciprofloxacin. Antimicrob. Agents Chemother. 36:2533-2535.
19. Shalit, I., S. A. Berger, A. Gorea, and H. Frimerman. 1989. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrob. Agents Chemother. 33:593-594.
20. Stratton, C. W., P. E. Johnston, and D. W. Haas. 1994. Lack of correlation between the use of a specific fluoroquinolone and the emergence of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa: a tale of two hospitals. Antimicrob. Infect. Dis. Newsl. 4:25-29.
21. Tankovic, J., J. Duval, and P. Courvalin. 1994. Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 9:35-40.
22. Tankovic, J., B. Perichon, J. Duval, and P. Courvalin. 1996. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob. Agents Chemother. 40:2505-2510.
23. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
24. Wiedemann, B., and P. Heisig. 1993. Quinolone resistance in gram-negative bacteria. Infect. Dis. Clin. Pract. 3(Suppl. 3):S115-S116.